Trial Profile
Clinical Trials Insight: 700012893
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Feb 2009
Price :
$35
*
At a glance
- Drugs Davunetide (Primary)
- Indications Dementia; Diabetic neuropathies; Eye disorders; Mild cognitive impairment; Stroke
- Focus Adverse reactions
- Sponsors Allon Therapeutics
- 03 Apr 2006 New trial record.